1. Home
  2. OTLK vs JRSH Comparison

OTLK vs JRSH Comparison

Compare OTLK & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Outlook Therapeutics Inc.

OTLK

Outlook Therapeutics Inc.

HOLD

Current Price

$1.92

Market Cap

92.8M

Sector

Health Care

ML Signal

HOLD

Logo Jerash Holdings (US) Inc.

JRSH

Jerash Holdings (US) Inc.

N/A

Current Price

$3.06

Market Cap

43.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
OTLK
JRSH
Founded
2010
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
92.8M
43.1M
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
OTLK
JRSH
Price
$1.92
$3.06
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$4.00
$4.00
AVG Volume (30 Days)
3.4M
87.2K
Earning Date
12-24-2025
11-12-2025
Dividend Yield
N/A
6.56%
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
$1,505,322.00
$146,234,005.00
Revenue This Year
N/A
$11.71
Revenue Next Year
$342.80
$7.69
P/E Ratio
N/A
$61.47
Revenue Growth
N/A
12.25
52 Week Low
$0.79
$2.81
52 Week High
$3.39
$4.17

Technical Indicators

Market Signals
Indicator
OTLK
JRSH
Relative Strength Index (RSI) 60.38 39.20
Support Level $1.51 $3.02
Resistance Level $2.10 $3.14
Average True Range (ATR) 0.16 0.10
MACD -0.00 0.00
Stochastic Oscillator 74.19 20.00

Price Performance

Historical Comparison
OTLK
JRSH

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

Share on Social Networks: